New population health data from CMS shows which patients are most affected by COVID-19. How might insights such as these advance value-based care and alternative payment models?
The Centers for Medicare and Medicaid Services (CMS) is updating its rules to encourage states, payers, and Medicare programs to enter value-based payment arrangements (VPA) with drug manufacturers to help reduce drug costs. What does this mean for Medicare providers and beneficiaries?
Privia Health’s Chief Clinical Officer Keith Fernandez, MD, shares his insights on ways providers can combat COVID-19 by leveraging technology, implementing telehealth, and practicing self-care.